CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday, September 12th at 10:45am Pacific Time. CytRx Corporation (NASDAQ:CYTR) belongs to Healthcare sector. weekly performance is 5.72%. On … Continue reading Today’s Hot List : CytRx Corporation (NASDAQ:CYTR), LipoScience, Inc. (NASDAQ:LPDX), India Fund, Inc. (NYSE:IFN), FreeSeas Inc. (NASDAQ:FREE), Enventis Corporation (NASDAQ:ENVE)